Header Logo

Connection

Alan Schneyer to Follistatin-Related Proteins

This is a "connection" page, showing publications Alan Schneyer has written about Follistatin-Related Proteins.
Connection Strength

3.047
  1. Brown ML, Andrzejewski D, Burnside A, Schneyer AL. Activin Enhances a- to ?-Cell Transdifferentiation as a Source For ?-Cells In Male FSTL3 Knockout Mice. Endocrinology. 2016 Mar; 157(3):1043-54.
    View in: PubMed
    Score: 0.498
  2. Brown ML, Bonomi L, Ungerleider N, Zina J, Kimura F, Mukherjee A, Sidis Y, Schneyer A. Follistatin and follistatin like-3 differentially regulate adiposity and glucose homeostasis. Obesity (Silver Spring). 2011 Oct; 19(10):1940-9.
    View in: PubMed
    Score: 0.360
  3. Mukherjee A, Sidis Y, Mahan A, Raher MJ, Xia Y, Rosen ED, Bloch KD, Thomas MK, Schneyer AL. FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults. Proc Natl Acad Sci U S A. 2007 Jan 23; 104(4):1348-53.
    View in: PubMed
    Score: 0.268
  4. Sidis Y, Mukherjee A, Keutmann H, Delbaere A, Sadatsuki M, Schneyer A. Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins. Endocrinology. 2006 Jul; 147(7):3586-97.
    View in: PubMed
    Score: 0.254
  5. Saito S, Sidis Y, Mukherjee A, Xia Y, Schneyer A. Differential biosynthesis and intracellular transport of follistatin isoforms and follistatin-like-3. Endocrinology. 2005 Dec; 146(12):5052-62.
    View in: PubMed
    Score: 0.244
  6. Schneyer A, Sidis Y, Xia Y, Saito S, del Re E, Lin HY, Keutmann H. Differential actions of follistatin and follistatin-like 3. Mol Cell Endocrinol. 2004 Oct 15; 225(1-2):25-8.
    View in: PubMed
    Score: 0.229
  7. Xia Y, Sidis Y, Schneyer A. Overexpression of follistatin-like 3 in gonads causes defects in gonadal development and function in transgenic mice. Mol Endocrinol. 2004 Apr; 18(4):979-94.
    View in: PubMed
    Score: 0.218
  8. Schneyer A, Schoen A, Quigg A, Sidis Y. Differential binding and neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-3/FSRP/FLRG). Endocrinology. 2003 May; 144(5):1671-4.
    View in: PubMed
    Score: 0.207
  9. Nam J, Perera P, Gordon R, Jeong YH, Blazek AD, Kim DG, Tee BC, Sun Z, Eubank TD, Zhao Y, Lablebecioglu B, Liu S, Litsky A, Weisleder NL, Lee BS, Butterfield T, Schneyer AL, Agarwal S. Follistatin-like 3 is a mediator of exercise-driven bone formation and strengthening. Bone. 2015 Sep; 78:62-70.
    View in: PubMed
    Score: 0.119
  10. Ungerleider NA, Bonomi LM, Brown ML, Schneyer AL. Increased activin bioavailability enhances hepatic insulin sensitivity while inducing hepatic steatosis in male mice. Endocrinology. 2013 Jun; 154(6):2025-33.
    View in: PubMed
    Score: 0.103
  11. Oldknow KJ, Seebacher J, Goswami T, Villen J, Pitsillides AA, O'Shaughnessy PJ, Gygi SP, Schneyer AL, Mukherjee A. Follistatin-like 3 (FSTL3) mediated silencing of transforming growth factor ? (TGF?) signaling is essential for testicular aging and regulating testis size. Endocrinology. 2013 Mar; 154(3):1310-20.
    View in: PubMed
    Score: 0.102
  12. Brown ML, Kimura F, Bonomi LM, Ungerleider NA, Schneyer AL. Differential synthesis and action of TGF? superfamily ligands in mouse and rat islets. Islets. 2011 Nov-Dec; 3(6):367-75.
    View in: PubMed
    Score: 0.093
  13. Thadhani R, Powe CE, Tjoa ML, Khankin E, Ye J, Ecker J, Schneyer A, Karumanchi SA. First-trimester follistatin-like-3 levels in pregnancies complicated by subsequent gestational diabetes mellitus. Diabetes Care. 2010 Mar; 33(3):664-9.
    View in: PubMed
    Score: 0.082
  14. Stamler R, Keutmann HT, Sidis Y, Kattamuri C, Schneyer A, Thompson TB. The structure of FSTL3.activin A complex. Differential binding of N-terminal domains influences follistatin-type antagonist specificity. J Biol Chem. 2008 Nov 21; 283(47):32831-8.
    View in: PubMed
    Score: 0.075
  15. Sidis Y, Schneyer AL, Keutmann HT. Heparin and activin-binding determinants in follistatin and FSTL3. Endocrinology. 2005 Jan; 146(1):130-6.
    View in: PubMed
    Score: 0.057
  16. Sidis Y, Tortoriello DV, Holmes WE, Pan Y, Keutmann HT, Schneyer AL. Follistatin-related protein and follistatin differentially neutralize endogenous vs. exogenous activin. Endocrinology. 2002 May; 143(5):1613-24.
    View in: PubMed
    Score: 0.048
  17. Tortoriello DV, Sidis Y, Holtzman DA, Holmes WE, Schneyer AL. Human follistatin-related protein: a structural homologue of follistatin with nuclear localization. Endocrinology. 2001 Aug; 142(8):3426-34.
    View in: PubMed
    Score: 0.046
  18. Schneyer A, Tortoriello D, Sidis Y, Keutmann H, Matsuzaki T, Holmes W. Follistatin-related protein (FSRP): a new member of the follistatin gene family. Mol Cell Endocrinol. 2001 Jun 30; 180(1-2):33-8.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.